JVC Stock Overview
Engages in the distribution of medical instruments and consumables in Vietnam. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Japan Vietnam Medical Investment and Development Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫3,510.00 |
| 52 Week High | ₫4,020.00 |
| 52 Week Low | ₫2,950.00 |
| Beta | 0 |
| 1 Month Change | 13.23% |
| 3 Month Change | 6.04% |
| 1 Year Change | 4.46% |
| 3 Year Change | -63.48% |
| 5 Year Change | -0.57% |
| Change since IPO | -80.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| JVC | VN Healthcare | VN Market | |
|---|---|---|---|
| 7D | 9.7% | -1.9% | -0.7% |
| 1Y | 4.5% | 0.7% | 13.0% |
Return vs Industry: JVC exceeded the VN Healthcare industry which returned 1.4% over the past year.
Return vs Market: JVC underperformed the VN Market which returned 13.7% over the past year.
Price Volatility
| JVC volatility | |
|---|---|
| JVC Average Weekly Movement | 3.3% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in VN Market | 6.7% |
| 10% least volatile stocks in VN Market | 1.9% |
Stable Share Price: JVC has not had significant price volatility in the past 3 months compared to the VN market.
Volatility Over Time: JVC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Nam Pham | www.ytevietnhat.com.vn |
Japan Vietnam Medical Investment and Development Joint Stock Company engages in the distribution of medical instruments and consumables in Vietnam. The company distributes medical equipment, including diagnostic imaging products, such as magnetic resonance imaging (MRI), computed tomography (CT), x-ray system, computed and direct radiography, dry imager, contrast injector, and diagnostic ultrasound products; CSSD comprising washers, dryers, and sterilizers; and anesthesia-emergency-ICU products, consisting of ultrasound systems, anesthesia and breathing machines, syringe and infusion pumps, and patient monitors, as well as consumable supplies, such as SD-S, DI-HT, Konica SD-Q, and DI-HL dry medical films; and central venous catheters and invasive blood pressure transducers for resuscitation-cardiovascular intervention. It also offers technical services, such as consulting, technical support, and repair and maintenance services; and IT services for hospitals.
Japan Vietnam Medical Investment and Development Joint Stock Company Fundamentals Summary
| JVC fundamental statistics | |
|---|---|
| Market cap | ₫394.88b |
| Earnings (TTM) | -₫31.69b |
| Revenue (TTM) | ₫499.43b |
0.0x
P/S Ratio0.0x
P/E RatioIs JVC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JVC income statement (TTM) | |
|---|---|
| Revenue | ₫499.43b |
| Cost of Revenue | ₫405.45b |
| Gross Profit | ₫93.98b |
| Other Expenses | ₫125.68b |
| Earnings | -₫31.69b |
Last Reported Earnings
Mar 31, 2017
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did JVC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/17 04:21 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2017/03/31 |
| Annual Earnings | 2017/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Japan Vietnam Medical Investment and Development Joint Stock Company is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dao Thi Nguyen | Viet Capital Securities Joint Stock Company |
| Barry Weisblatt | VPS Securities JSC, Research Division |